-
Je něco špatně v tomto záznamu ?
Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted 177Lu-Labeled Cancer Theranostics
T. Rheinfrank, V. Lebruška, S. Stangl, M. Vojtíčková, NT. Nguyen, L. Koller, J. Šimeček, V. Kubíček, S. Kossatz, J. Notni
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- antigeny nádorové * metabolismus MeSH
- chelátory * chemie MeSH
- click chemie MeSH
- integriny * metabolismus MeSH
- lidé MeSH
- lutecium * chemie MeSH
- myši nahé MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nádory farmakoterapie MeSH
- oligopeptidy * chemie farmakokinetika MeSH
- radiofarmaka farmakokinetika chemie terapeutické užití MeSH
- radionuklidy * chemie MeSH
- teranostická nanomedicína metody MeSH
- tkáňová distribuce MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The cellular adhesion receptor αvβ6-integrin is highly expressed in many cancers, e.g., pancreatic, lung, head-and-neck, cervical, bladder, and esophageal carcinoma. Multimerization of αvβ6-integrin-specific RGD peptides increases the target affinity and retention but affects biodistribution and pharmacokinetics. Amide formation of the terminal carboxylic acid moieties of the square-symmetrical bifunctional chelator DOTPI with 3-azidopropylamine yields derivatives with 4, 3, and 2 terminal azides and zero, 1, and 2 remaining carboxylic acids, respectively, whereby formation of the 2-cis-isomer is preferred according to NMR investigation of the Eu(III)-complexes. Cu(II)-catalyzed alkyne-azide cycloaddition (CuAAC) of the alkyne-functionalized αvβ6-integrin binding peptide cyclo[YRGDLAYp(NMe)K(pent-4-ynoic amide)] (Tyr2) yields the respective di-, tri-, and tetrameric conjugates for Lu-177-labeling. In mice bearing αvβ6-integrin-expressing xenografts of H2009 (human lung adenocarcinoma) cells, the Lu-177-labeled trimer's tumor-to-blood ratio of 112 exceeds that of the tetramer (10.4) and the dimer (54). Co-infusion of gelofusine (succinylated gelatin) reduces the renal uptake of the trimer by 89%, resulting in a 10-fold better tumor-to-kidney ratio, while no improvement of that ratio is observed with arginine/lysine, para-aminohippuric acid (PAH), and hydroxyethyl starch (HES) coinfusions. Since the Lu-177-labeled Tyr2-trimer outperforms the dimer and the tetramer, such trimers are considered the best lead structures for the ongoing development of αvβ6-integrin targeted anticancer theranostics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003017
- 003
- CZ-PrNML
- 005
- 20250206104016.0
- 007
- ta
- 008
- 250121s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.bioconjchem.4c00481 $2 doi
- 035 __
- $a (PubMed)39608839
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rheinfrank, Tim $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
- 245 10
- $a Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted 177Lu-Labeled Cancer Theranostics / $c T. Rheinfrank, V. Lebruška, S. Stangl, M. Vojtíčková, NT. Nguyen, L. Koller, J. Šimeček, V. Kubíček, S. Kossatz, J. Notni
- 520 9_
- $a The cellular adhesion receptor αvβ6-integrin is highly expressed in many cancers, e.g., pancreatic, lung, head-and-neck, cervical, bladder, and esophageal carcinoma. Multimerization of αvβ6-integrin-specific RGD peptides increases the target affinity and retention but affects biodistribution and pharmacokinetics. Amide formation of the terminal carboxylic acid moieties of the square-symmetrical bifunctional chelator DOTPI with 3-azidopropylamine yields derivatives with 4, 3, and 2 terminal azides and zero, 1, and 2 remaining carboxylic acids, respectively, whereby formation of the 2-cis-isomer is preferred according to NMR investigation of the Eu(III)-complexes. Cu(II)-catalyzed alkyne-azide cycloaddition (CuAAC) of the alkyne-functionalized αvβ6-integrin binding peptide cyclo[YRGDLAYp(NMe)K(pent-4-ynoic amide)] (Tyr2) yields the respective di-, tri-, and tetrameric conjugates for Lu-177-labeling. In mice bearing αvβ6-integrin-expressing xenografts of H2009 (human lung adenocarcinoma) cells, the Lu-177-labeled trimer's tumor-to-blood ratio of 112 exceeds that of the tetramer (10.4) and the dimer (54). Co-infusion of gelofusine (succinylated gelatin) reduces the renal uptake of the trimer by 89%, resulting in a 10-fold better tumor-to-kidney ratio, while no improvement of that ratio is observed with arginine/lysine, para-aminohippuric acid (PAH), and hydroxyethyl starch (HES) coinfusions. Since the Lu-177-labeled Tyr2-trimer outperforms the dimer and the tetramer, such trimers are considered the best lead structures for the ongoing development of αvβ6-integrin targeted anticancer theranostics.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a integriny $x metabolismus $7 D016023
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a oligopeptidy $x chemie $x farmakokinetika $7 D009842
- 650 _2
- $a myši $7 D051379
- 650 12
- $a chelátory $x chemie $7 D002614
- 650 12
- $a lutecium $x chemie $7 D008187
- 650 12
- $a radionuklidy $x chemie $7 D011868
- 650 12
- $a antigeny nádorové $x metabolismus $7 D000951
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 _2
- $a click chemie $7 D057930
- 650 _2
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a radiofarmaka $x farmakokinetika $x chemie $x terapeutické užití $7 D019275
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a teranostická nanomedicína $x metody $7 D000068936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lebruška, Viktor $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic
- 700 1_
- $a Stangl, Stefan $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
- 700 1_
- $a Vojtíčková, Margareta $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic
- 700 1_
- $a Nguyen, Nghia Trong $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
- 700 1_
- $a Koller, Lena $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
- 700 1_
- $a Šimeček, Jakub $u TRIMT GmbH, Carl-Eschebach-Str. 7, 01454 Radeberg, Germany
- 700 1_
- $a Kubíček, Vojtěch $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic $1 https://orcid.org/0000000301715713 $7 uk2007350367
- 700 1_
- $a Kossatz, Susanne $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
- 700 1_
- $a Notni, Johannes $u TRIMT GmbH, Carl-Eschebach-Str. 7, 01454 Radeberg, Germany $u Institute of Pathology, School of Medicine, Technical University Munich, Trogerstr. 18, D-81675 München, Germany $1 https://orcid.org/0000000239643391
- 773 0_
- $w MED00006454 $t Bioconjugate chemistry $x 1520-4812 $g Roč. 35, č. 12 (2024), s. 1970-1984
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39608839 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104011 $b ABA008
- 999 __
- $a ok $b bmc $g 2263043 $s 1239024
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 35 $c 12 $d 1970-1984 $e 20241128 $i 1520-4812 $m Bioconjugate chemistry $n Bioconjug Chem $x MED00006454
- LZP __
- $a Pubmed-20250121